Delivery Order SPE2DB22D3301-SPE2DB25FY7CM

Award Date 7/1/25
Potential Completion Date 7/2/25
Potential Value $7.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,061.13 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NAYZILAM 5 MG NASAL SPRAYS. The contract has an ultimate completion date of August 1, 2024 and does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for delivering a wide...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NAYZILAM 5 MG NASAL SPRAYS, a pharmaceutical product, with a ceiling value of $1,407.17 and a period of performance ending on July 2, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NAYZILAM 5 MG NASAL SPRAYS, with a ceiling value of $2,147.48 and a completion date of May 27, 2025. The contract is a firm fixed-price, non-set-aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of NAYZILAM 5 mg nasal sprays, with a ceiling value of $2,388.74 and a period of performance ending on April 1, 2025. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of NAYZILAM 5 MG NASAL SPRAYS. The order has a ceiling value of $8,907.04 and is a firm fixed price contract. The ultimate completion date is September 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of NAYZILAM 5 MG NASAL SPRAYS, with a ceiling value of $1,103.59 and a performance period through June 10, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,759.12, is for the supply of NAYZILAM 5 MG NASAL SPRAYS to support federal government healthcare programs. The contract is a firm fixed-price delivery order, with an ultimate completion date of December 27, 2024. It is not designated as a set-aside contract, indicating open competition....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NAYZILAM 5 MG NASAL SPRAYS, with a ceiling value of $1,821.49 and a performance period ending on May 16, 2025. The contract is a firm fixed-price delivery order, which is not set-aside for any particular business category. Amerisourcebergen Drug Corp holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NAYZILAM 5 MG nasal sprays. The $1,152.24 firm fixed-price contract has a completion date of November 5, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Nayzilam 5 mg nasal sprays. The contract has a firm fixed price, with a ceiling value of $2,434.06, and a period of performance through May 6, 2025. The contract is not set aside for any specific type of business. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FY7CM
    Delivery Order

This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NAYZILAM 5 MG NASAL SPRAYS. The contract has a ceiling value of $7,333.23 and a period of performance through July 2, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is not set aside and represents an open competition award, highlighting AmerisourceBergen's capacity to fulfill varied federal medical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government agencies.

Generated 9/30/25, 10:06 AM